Profil
Michael E.
Dambach is currently the Treasurer, Director & Vice President at Stromedix, Inc. He also holds the position of Treasurer & Vice President at Biogen, Inc. since 2010.
Previously, he served as Treasurer & Director at Bioverativ Therapeutics, Inc. and as an Independent Director at BiomX, Inc. from 2023 to 2024.
He also worked as an Assistant Treasurer at Thermo Fisher Scientific, Inc. Mr. Dambach holds an MBA from Boston University and an undergraduate degree from the University of New Hampshire.
Postes actifs de Michael Dambach
| Sociétés | Poste | Début |
|---|---|---|
| BIOGEN INC. | Treasurer | 01/01/2010 |
Stromedix, Inc.
 Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Stromedix, Inc. develops novel drugs to treat fibrosis and fibrotic organ failure. The company was founded by Michael Gilman in 2006 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Anciens postes connus de Michael Dambach
| Sociétés | Poste | Fin |
|---|---|---|
| BIOMX INC. | Director/Board Member | 15/03/2024 |
| THERMO FISHER SCIENTIFIC | Corporate Officer/Principal | - |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Director/Board Member | - |
Formation de Michael Dambach
| Boston University | Masters Business Admin |
| University of New Hampshire | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| THERMO FISHER SCIENTIFIC | Health Technology |
| BIOMX INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Health Technology |
Stromedix, Inc.
Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Stromedix, Inc. develops novel drugs to treat fibrosis and fibrotic organ failure. The company was founded by Michael Gilman in 2006 and is headquartered in Cambridge, MA. | Health Technology |
